-
Mashup Score: 15
At the 2024 Lymphoma, Leukemia & Myeloma Congress, Mrinal Patnaik, MD, discusses strategies for diagnosing and treating patients with chronic myelomonocytic leukemia.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 104Clonal Monocytosis of Renal Significance - PubMed - 18 day(s) ago
Clonal monocytosis reflects a preneoplastic or neoplastic sustained increase in the absolute monocyte count in the absence of reactive causes. Causes of clonal monocytosis include clonal cytopenias with monocytosis and acute and chronic myeloid neoplasms. Chronic myelomonocytic leukemia (CMML) is a …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 16Pancreatitis as a Potential Consequence of Danazol Therapy for Telomere Biology Disorders - PubMed - 26 day(s) ago
Pancreatitis as a Potential Consequence of Danazol Therapy for Telomere Biology Disorders
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2An ancient gene gives spiders their teeny waistlines - 2 month(s) ago
Researchers identify gene responsible for the arachnids’ signature hourglass shape
Source: www.science.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 42
AKI is an underrecognized feature of VEXAS occurring in 25% of patients in this cohort. Age at diagnosis and CRP were associated with time to first AKI event during follow up. Plasma cell-rich interstitial nephritis was the most common histopathologic finding.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 39
AKI is an underrecognized feature of VEXAS occurring in 25% of patients in this cohort. Age at diagnosis and CRP were associated with time to first AKI event during follow up. Plasma cell-rich interstitial nephritis was the most common histopathologic finding.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 26RNA shielding of P65 is required to potentiate oncogenic inflammation in TET2 mutated clonal hematopoiesis - PubMed - 2 month(s) ago
TET2 mutations (mTET2) are common genetic events in myeloid malignancies and clonal hematopoiesis (CH). These mutations arise in the founding clone and are implicated in many clinical sequelae associated with oncogenic feedforward inflammatory circuits. However, the direct downstream effector of mTE …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 15How DNA guides cancer detection | Tomorrow's Cure Episode 3 - 3 month(s) ago
What if you knew you’d get sick before you ever felt symptoms? If it were a cold, that information is useful. In the case of cancer, it is lifesaving. Find o…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 28Clonal Hematopoiesis in Patients With Neuroendocrine Tumor Treated With Lutetium-177 and the Risk of Thrombocytopenia: A Prospective Study - PubMed - 3 month(s) ago
CH is present in 35.1% of patients with NET and is associated with thrombocytopenia risk during PRRT. Future studies with long-term follow-up will delineate whether CH might be a predictor for higher risk of t-MN after PRRT.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 31
Not available.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
Exploring Diagnostic Criteria and Treatment Options for Patients With CMML https://t.co/bX6wYW2kuQ #CMML @MayoCancerCare @llmcongress @LLSusa